Latest News

Collegium Pharmaceutical (NASDAQ:COLL) reported record third-quarter 2026 revenue as growth in its attention-deficit/hyperactivity disorder portfolio helped offset declining sales of pain medicines. The company reaffirmed its full-year outlook, though quarterly earnings fell from a year earlier. To

Krispy Kreme (NASDAQ:DNUT) raised its 2026 revenue outlook after reporting third-quarter sales growth in its U.S. fresh delivery business and further cost reductions, though reported revenue and adjusted earnings declined as the company refranchised operations. The doughnut chain expects full-year

GPGI lowered its full-year 2026 profit and cash flow outlook as delayed cost reductions and an unfavorable product mix at Husky offset continued growth at CompoSecure (NASDAQ:CMPO), executives said on the company’s third-quarter earnings call. Executive Chairman Dave Cote said GPGI still expects to

1stdibs.com (NASDAQ:DIBS) reported higher third-quarter revenue and a return to order growth, as the online marketplace announced that Bradford Shellhammer will succeed David Rosenblatt as chief executive officer on January 1, 2027. Gross merchandise value, or GMV, rose 4% year over year to $92.6 m

Apyx Medical (NASDAQ:APYX) reported a 9% increase in third-quarter 2026 revenue, driven by sales of its AYON body contouring system in the United States and international demand for Renuvion. The company also narrowed its full-year operating expense target while reaffirming its revenue outlook. Rev

Brilliant Earth Group (NASDAQ:BRLT) reported higher third-quarter sales and a wider gross margin, but offered a measured holiday-season outlook as customers face tighter budgets for engagement rings. Net sales rose approximately 2% year over year to $112.8 million, above the company’s guidance, whi

Appian (NASDAQ:APPN) reported 25% revenue growth in the third quarter of 2026 and raised its full-year outlook, as demand for artificial intelligence tools and self-managed software contributed to what executives described as a strong period for new business. Revenue rose to $235 million, while clo

ACM Research (NASDAQ:ACMR) raised its full-year revenue outlook after reporting a 36.6% increase in third-quarter sales, citing a growing order backlog, new product cycles and production execution. The semiconductor equipment maker now expects 2026 revenue of $1.24 billion to $1.28 billion, up 38%

Acacia Research (NASDAQ:ACTG) reported lower third-quarter revenue and a net loss, as weaker demand at its Deflecto manufacturing business offset strength at its energy operations and gains from public securities investments. Revenue fell to $54.4 million from $59.4 million a year earlier. The comp

SGL Carbon (ETR:SGL) raised its 2026 earnings outlook after a stronger-than-expected third quarter, as a ramp-up in nuclear graphite production and improved profitability in its composites business offset continued weakness in equipment supplied to the chemical industry. The company reported nine-m

Sale of BioReference brings $722 million in cash as the company narrows its focus to biotech.

Security sales jumped 32% as large customers deepened platform usage.

Total company profitability arrived early as MRD guidance moved higher.

Long-term contracts and new markets are shaping the outlook behind another guidance raise.

Management weighed a European milestone and new glioma data ahead of 2027.

Revenue recognition shifts are reshaping reported results as management lifts its full-year outlook.

The lodging REIT delivered strong earnings and raised its outlook, but does that make its stock a buy?

Assuming the economy and the stock market remain relatively normal and avoid any unusually prolonged weakness, Greg Abel could do nothing else from here and still reach this target.

Credit card growth and shipping costs shaped this quarter's results.

Fortis (TSX:FTS) has delivered on dividend hikes over the decades and it's not done yet!

Management says the sourcing transition is behind it, and the freight bill is climbing.

The game engine maker's AI-powered ad business is now big enough to carry the whole company, but its creator tools are slowing.

The energy drink maker's growth now depends on its newer brands, and rising costs are keeping profit from following sales.

Palantir stock may not be as expensive as it looks.

Matador Resources posted strong Q3 revenue growth, raised its dividend, and drew bullish analyst coverage, though shares have stayed range-bound despite insider and institutional buying.